WayUp Abroad Now Offers Management Quota Admission in UK for Indian Students
Expanding opportunities for Indian students to study in UK with flexible admission options and expert guidance
Education Press Releases
Education press releases from universities, schools, EdTech companies, and research institutions.
29 press releases found
M&M's Recall Hits 20 States Over Missing Allergen Warnings
Beacon Promotions Inc. recalls repackaged M&M's in 20 states. Packages lack required allergen labels for milk, soy, and peanuts; FDA classifies the recall as Class II.
Ozempic vs Wegovy vs Mounjaro: How the Weight-Loss Drugs Compare in 2025
Ozempic and Wegovy use semaglutide; Mounjaro uses tirzepatide. In head-to-head trials, tirzepatide led to greater weight loss. Here's the comparison and what to discuss with your d…
Medicare Open Enrollment 2026: Dates, Premium Changes, and What to Do
Medicare open enrollment for 2026 runs October 15–December 7, 2025. Premiums drop, drug cap hits $2,100, and vaccines are free. What to know.
ChatGPT Health: How 40 Million People Use AI for Healthcare Questions
OpenAI says 40 million people use ChatGPT for health-related queries. ChatGPT Health can use medical records. Here's what that means and the risks.
Wegovy Pill Approved as GLP-1 Supply Eases and Pricing Shifts in 2026
Novo Nordisk's oral Wegovy received FDA approval in January 2026. Supply shortages have eased while government pricing deals and weight-regain data reshape the obesity drug market.
CDC Finds Silent Bird Flu Infections in U.S. Dairy Veterinarians
A CDC serosurvey of 150 bovine veterinarians found three with undetected H5N1 infections. Two had no known exposure to infected herds, suggesting wider spread than official counts.
Moderna mRNA Flu Vaccine Clears FDA Hurdle, Decision Set for August
Moderna's mRNA flu vaccine mRNA-1010 wins FDA review after initial rejection, with a decision date of August 5, 2026 for potential approval.
Retatrutide Phase 3 Data Shows 29% Weight Loss, Rivaling Surgery
Eli Lilly's retatrutide triple agonist achieves 28.7% weight loss in TRIUMPH-4 trial, matching bariatric surgery outcomes and reshaping obesity treatment.